You can view cancer
heterogeneity on several levels. There is
genetic heterogeneity—
copy-number
variations or point
mutations and so
on. So that’s at the
level of somatic
cells. Then there is
the issue of heterogeneity
in the germline
background,
not only in the
tumor but also in
the tumor stroma. I